nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—Hypoxemia—Methotrexate—systemic scleroderma	0.0389	0.0389	CcSEcCtD
Mivacurium—Wheezing—Mometasone—systemic scleroderma	0.0245	0.0245	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.022	0.022	CcSEcCtD
Mivacurium—Bronchospasm—Pentoxifylline—systemic scleroderma	0.0181	0.0181	CcSEcCtD
Mivacurium—Wheezing—Mycophenolic acid—systemic scleroderma	0.017	0.017	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Captopril—systemic scleroderma	0.0167	0.0167	CcSEcCtD
Mivacurium—Bronchospasm—Mometasone—systemic scleroderma	0.0156	0.0156	CcSEcCtD
Mivacurium—Wheezing—Lisinopril—systemic scleroderma	0.0153	0.0153	CcSEcCtD
Mivacurium—Phlebitis—Mycophenolic acid—systemic scleroderma	0.0147	0.0147	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Mivacurium—Bronchospasm—Captopril—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Mivacurium—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Mivacurium—Flushing—Pentoxifylline—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Mivacurium—Immune system disorder—Pentoxifylline—systemic scleroderma	0.0133	0.0133	CcSEcCtD
Mivacurium—Arrhythmia—Pentoxifylline—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Mivacurium—Erythema—Pentoxifylline—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Mivacurium—Muscle spasms—Pentoxifylline—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Mivacurium—Hypoxia—Methotrexate—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Mivacurium—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Mivacurium—Immune system disorder—Mometasone—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Mivacurium—Mediastinal disorder—Mometasone—systemic scleroderma	0.0114	0.0114	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Mivacurium—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.0105	0.0105	CcSEcCtD
Mivacurium—Flushing—Captopril—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Mivacurium—Tachycardia—Pentoxifylline—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Mivacurium—Skin disorder—Pentoxifylline—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Mivacurium—Hypotension—Pentoxifylline—systemic scleroderma	0.00977	0.00977	CcSEcCtD
Mivacurium—Bronchospasm—Lisinopril—systemic scleroderma	0.0097	0.0097	CcSEcCtD
Mivacurium—Anaphylactic shock—Mometasone—systemic scleroderma	0.00902	0.00902	CcSEcCtD
Mivacurium—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00892	0.00892	CcSEcCtD
Mivacurium—Immune system disorder—Azathioprine—systemic scleroderma	0.00879	0.00879	CcSEcCtD
Mivacurium—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00877	0.00877	CcSEcCtD
Mivacurium—Arrhythmia—Azathioprine—systemic scleroderma	0.00869	0.00869	CcSEcCtD
Mivacurium—Cardiac disorder—Leflunomide—systemic scleroderma	0.00853	0.00853	CcSEcCtD
Mivacurium—Urticaria—Pentoxifylline—systemic scleroderma	0.0083	0.0083	CcSEcCtD
Mivacurium—Immune system disorder—Leflunomide—systemic scleroderma	0.0083	0.0083	CcSEcCtD
Mivacurium—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00828	0.00828	CcSEcCtD
Mivacurium—Arrhythmia—Leflunomide—systemic scleroderma	0.00821	0.00821	CcSEcCtD
Mivacurium—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00814	0.00814	CcSEcCtD
Mivacurium—Bradycardia—Lisinopril—systemic scleroderma	0.00804	0.00804	CcSEcCtD
Mivacurium—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00795	0.00795	CcSEcCtD
Mivacurium—Anaphylactic shock—Captopril—systemic scleroderma	0.00792	0.00792	CcSEcCtD
Mivacurium—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.0079	0.0079	CcSEcCtD
Mivacurium—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00783	0.00783	CcSEcCtD
Mivacurium—Tachycardia—Captopril—systemic scleroderma	0.00773	0.00773	CcSEcCtD
Mivacurium—Muscle spasms—Leflunomide—systemic scleroderma	0.00769	0.00769	CcSEcCtD
Mivacurium—Hypotension—Captopril—systemic scleroderma	0.0074	0.0074	CcSEcCtD
Mivacurium—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00734	0.00734	CcSEcCtD
Mivacurium—Flushing—Lisinopril—systemic scleroderma	0.00733	0.00733	CcSEcCtD
Mivacurium—Angiopathy—Lisinopril—systemic scleroderma	0.00716	0.00716	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00716	0.00716	CcSEcCtD
Mivacurium—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00712	0.00712	CcSEcCtD
Mivacurium—Arrhythmia—Lisinopril—systemic scleroderma	0.00705	0.00705	CcSEcCtD
Mivacurium—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00704	0.00704	CcSEcCtD
Mivacurium—Dizziness—Pentoxifylline—systemic scleroderma	0.00691	0.00691	CcSEcCtD
Mivacurium—Erythema—Lisinopril—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Mivacurium—Skin disorder—Azathioprine—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Mivacurium—Muscle spasms—Lisinopril—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Mivacurium—Rash—Pentoxifylline—systemic scleroderma	0.00659	0.00659	CcSEcCtD
Mivacurium—Dermatitis—Pentoxifylline—systemic scleroderma	0.00658	0.00658	CcSEcCtD
Mivacurium—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Mivacurium—Hypotension—Azathioprine—systemic scleroderma	0.00646	0.00646	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Mivacurium—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00642	0.00642	CcSEcCtD
Mivacurium—Tachycardia—Leflunomide—systemic scleroderma	0.00637	0.00637	CcSEcCtD
Mivacurium—Skin disorder—Leflunomide—systemic scleroderma	0.00634	0.00634	CcSEcCtD
Mivacurium—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00628	0.00628	CcSEcCtD
Mivacurium—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00623	0.00623	CcSEcCtD
Mivacurium—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00618	0.00618	CcSEcCtD
Mivacurium—Hypotension—Leflunomide—systemic scleroderma	0.0061	0.0061	CcSEcCtD
Mivacurium—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00608	0.00608	CcSEcCtD
Mivacurium—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00585	0.00585	CcSEcCtD
Mivacurium—Hypotension—Mycophenolic acid—systemic scleroderma	0.00582	0.00582	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00581	0.00581	CcSEcCtD
Mivacurium—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00579	0.00579	CcSEcCtD
Mivacurium—Rash—Mometasone—systemic scleroderma	0.00569	0.00569	CcSEcCtD
Mivacurium—Dermatitis—Mometasone—systemic scleroderma	0.00568	0.00568	CcSEcCtD
Mivacurium—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00561	0.00561	CcSEcCtD
Mivacurium—Tachycardia—Lisinopril—systemic scleroderma	0.00547	0.00547	CcSEcCtD
Mivacurium—Skin disorder—Lisinopril—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Mivacurium—Hypotension—Lisinopril—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Mivacurium—Dizziness—Captopril—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Mivacurium—Urticaria—Leflunomide—systemic scleroderma	0.00519	0.00519	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00509	0.00509	CcSEcCtD
Mivacurium—Rash—Captopril—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Mivacurium—Dermatitis—Captopril—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Mivacurium—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Mivacurium—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Mivacurium—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Mivacurium—Bradycardia—Prednisone—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Mivacurium—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Mivacurium—Dizziness—Azathioprine—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Mivacurium—Urticaria—Lisinopril—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Mivacurium—Rash—Azathioprine—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Mivacurium—Dermatitis—Azathioprine—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Mivacurium—Flushing—Prednisone—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Mivacurium—Dizziness—Leflunomide—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Mivacurium—Angiopathy—Prednisone—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Mivacurium—Immune system disorder—Prednisone—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Mivacurium—Arrhythmia—Prednisone—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Mivacurium—Dizziness—Mycophenolic acid—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Mivacurium—Rash—Leflunomide—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Mivacurium—Dermatitis—Leflunomide—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Mivacurium—Erythema—Prednisone—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Mivacurium—Rash—Mycophenolic acid—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Mivacurium—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Mivacurium—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Mivacurium—Dizziness—Lisinopril—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Mivacurium—Cardiac disorder—Methotrexate—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Mivacurium—Angiopathy—Methotrexate—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Mivacurium—Immune system disorder—Methotrexate—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Mivacurium—Rash—Lisinopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Mivacurium—Dermatitis—Lisinopril—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Mivacurium—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Mivacurium—Erythema—Methotrexate—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisone—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Mivacurium—Tachycardia—Prednisone—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Mivacurium—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Mivacurium—Skin disorder—Prednisone—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Mivacurium—Rash—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Mivacurium—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Mivacurium—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Mivacurium—Skin disorder—Methotrexate—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Mivacurium—Urticaria—Prednisone—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Mivacurium—Hypotension—Methotrexate—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Mivacurium—Urticaria—Methotrexate—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Mivacurium—Dizziness—Prednisone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Mivacurium—Rash—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Mivacurium—Dermatitis—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Mivacurium—Dizziness—Methotrexate—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Mivacurium—Rash—Methotrexate—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Mivacurium—Dermatitis—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
